Oncolytic Virotherapy Market: Is 2026 the Year "Cold"...

adicionou um novo artigo Health

2026-02-12 06:07:21 -

Oncolytic Virotherapy Market: Is 2026 the Year "Cold" Brain Tumors Finally Turn "Hot" Enough for a Cure?

In early 2026, the Oncolytic Virotherapy Market has reached a pivotal valuation of $7.78 billion, signaling the transition of viral immunotherapy from a niche alternative to a mainstream oncology pillar. This year, the industry is celebrating a "Glioblastoma Breakthrough," as recent data from Mass General Brigham and Dana-Farber showed that a single injection of an engineered herpes virus...

0 Comentários 0 Compartilhamentos 16 Visualizações 0 Anterior